These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 17703303)

  • 1. Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis.
    Logan RM; Gibson RJ; Bowen JM; Stringer AM; Sonis ST; Keefe DM
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):33-41. PubMed ID: 17703303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered?
    Logan RM; Stringer AM; Bowen JM; Gibson RJ; Sonis ST; Keefe DM
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):239-51. PubMed ID: 18351341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in the dark agouti rat.
    Al-Dasooqi N; Gibson RJ; Bowen JM; Logan RM; Stringer AM; Keefe DM
    Exp Biol Med (Maywood); 2010 Oct; 235(10):1244-56. PubMed ID: 20682600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile.
    Stringer AM; Gibson RJ; Bowen JM; Logan RM; Ashton K; Yeoh AS; Al-Dasooqi N; Keefe DM
    Int J Exp Pathol; 2009 Oct; 90(5):489-99. PubMed ID: 19765103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell adhesion molecules are altered during irinotecan-induced mucositis: a qualitative histopathological study.
    Al-Dasooqi N; Bowen J; Bennett C; Finnie J; Keefe D; Gibson R
    Support Care Cancer; 2017 Feb; 25(2):391-398. PubMed ID: 27650103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation.
    Lima-Júnior RC; Figueiredo AA; Freitas HC; Melo ML; Wong DV; Leite CA; Medeiros RP; Marques-Neto RD; Vale ML; Brito GA; Oriá RB; Souza MH; Cunha FQ; Ribeiro RA
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):931-42. PubMed ID: 22101361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irinotecan-induced mucositis is associated with changes in intestinal mucins.
    Stringer AM; Gibson RJ; Logan RM; Bowen JM; Yeoh AS; Laurence J; Keefe DM
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):123-32. PubMed ID: 18998135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of cytokines (TNF-alpha, IL-1beta and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: effect of pentoxifylline and thalidomide.
    Melo ML; Brito GA; Soares RC; Carvalho SB; Silva JV; Soares PM; Vale ML; Souza MH; Cunha FQ; Ribeiro RA
    Cancer Chemother Pharmacol; 2008 Apr; 61(5):775-84. PubMed ID: 17624531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy-induced diarrhea is associated with changes in the luminal environment in the DA rat.
    Stringer AM; Gibson RJ; Logan RM; Bowen JM; Yeoh AS; Burns J; Keefe DM
    Exp Biol Med (Maywood); 2007 Jan; 232(1):96-106. PubMed ID: 17202590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum-derived bovine immunoglobulin/protein isolate in the alleviation of chemotherapy-induced mucositis.
    Bateman E; Weaver E; Klein G; Wignall A; Wozniak B; Plews E; Mayo B; White I; Keefe D
    Support Care Cancer; 2016 Jan; 24(1):377-385. PubMed ID: 26081596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irinotecan changes gene expression in the small intestine of the rat with breast cancer.
    Bowen JM; Gibson RJ; Cummins AG; Tyskin A; Keefe DM
    Cancer Chemother Pharmacol; 2007 Feb; 59(3):337-48. PubMed ID: 16799812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wumei pills attenuates 5-fluorouracil-induced intestinal mucositis through Toll-like receptor 4/myeloid differentiation factor 88/nuclear factor-κB pathway and microbiota regulation.
    Lu DX; Liu F; Wu H; Liu HX; Chen BY; Yan J; Lu Y; Sun ZG
    World J Gastroenterol; 2022 Aug; 28(32):4574-4599. PubMed ID: 36157934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. St. John's wort attenuates irinotecan-induced diarrhea via down-regulation of intestinal pro-inflammatory cytokines and inhibition of intestinal epithelial apoptosis.
    Hu ZP; Yang XX; Chan SY; Xu AL; Duan W; Zhu YZ; Sheu FS; Boelsterli UA; Chan E; Zhang Q; Wang JC; Ee PL; Koh HL; Huang M; Zhou SF
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):225-37. PubMed ID: 17015070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of Saccharomyces boulardii on reducing irinotecan-induced intestinal mucositis and diarrhea.
    Sezer A; Usta U; Cicin I
    Med Oncol; 2009; 26(3):350-7. PubMed ID: 19067257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irinotecan disrupts tight junction proteins within the gut : implications for chemotherapy-induced gut toxicity.
    Wardill HR; Bowen JM; Al-Dasooqi N; Sultani M; Bateman E; Stansborough R; Shirren J; Gibson RJ
    Cancer Biol Ther; 2014 Feb; 15(2):236-44. PubMed ID: 24316664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvacryl acetate, a novel semisynthetic monoterpene ester, binds to the TRPA1 receptor and is effective in attenuating irinotecan-induced intestinal mucositis in mice.
    Alvarenga EM; Sousa NA; de Araújo S; Júnior JLP; Araújo AR; Iles B; Pacífico DM; Brito GAC; Souza EP; Sousa DP; Medeiros JVR
    J Pharm Pharmacol; 2017 Dec; 69(12):1773-1785. PubMed ID: 28940490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a single-dose irinotecan model of gastrointestinal mucositis.
    Gibson RJ; Bowen JM; Alvarez E; Finnie J; Keefe DM
    Chemotherapy; 2007; 53(5):360-9. PubMed ID: 17713326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irinotecan induces enterocyte cell death and changes to muc2 and muc4 composition during mucositis in a tumour-bearing DA rat model.
    Thorpe D; Sultani M; Stringer A
    Cancer Chemother Pharmacol; 2019 May; 83(5):893-904. PubMed ID: 30815720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives.
    Ribeiro RA; Wanderley CW; Wong DV; Mota JM; Leite CA; Souza MH; Cunha FQ; Lima-Júnior RC
    Cancer Chemother Pharmacol; 2016 Nov; 78(5):881-893. PubMed ID: 27590709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of NFkappaB and pro-inflammatory cytokines following administration of mucotoxic drugs.
    Logan RM; Stringer AM; Bowen JM; Gibson RJ; Sonis ST; Keefe DM
    Cancer Biol Ther; 2008 Jul; 7(7):1139-45. PubMed ID: 18535404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.